Two Sigma Advisers’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $54K | Buy |
|
|||||
|
2022
Q3 | $195K | Buy |
|
|||||
|
2022
Q2 | $64K | Sell |
|
|||||
|
2022
Q1 | $100K | Sell |
|
|||||
|
2021
Q4 | $174K | Sell |
|
|||||
|
2021
Q3 | $740K | Sell |
|
|||||
|
2021
Q2 | $1.5M | Sell |
|
|||||
|
2021
Q1 | $3M | Sell |
|
|||||
|
2020
Q4 | $4.8M | Buy |
|
|||||
|
2020
Q3 | $2.66M | Buy |
|
|||||
|
2020
Q2 | $2.56M | Buy |
|
|||||
|
2020
Q1 | $1.54M | Buy |
|
|||||
|
2019
Q4 | $1.07M | Buy |
|
|||||
|
2019
Q3 | $177K | Sell |
|
|||||
|
2019
Q2 | $272K | Buy |
|
|||||
|
2019
Q1 | $240K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $142K | Sell |
|
|||||
|
2015
Q3 | $109K | Sell |
|
|||||
|
2015
Q2 | $183K | Buy |
|
|||||
|
2015
Q1 | $237K | Buy |
|